Valeant, Pershing End Spat With Allergan Over Takeover Bid

By Pete Brush (April 9, 2015, 5:50 PM EDT) -- Valeant Pharmaceuticals International Inc. and William Ackman's Pershing Square Capital Management LP hedge fund agreed Thursday to bury the hatchet with Allergan Inc. after the sides lobbed damages claims at one other tied to Valeant and Pershing's failed bid to buy the Botox maker in a $55 billion hostile takeover....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!